FDA’s Prasad Weathers Personal Controversy, Internal Strife Amid Moderna Imbroglio

Vinay Prasad, the FDA’s Center for Biologics Evaluation and Research head, is accused of interpersonal impropriety as pushback builds against his decision to reject Moderna’s influenza vaccine candidate.